Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sotorasib and Omeprazole DDI Study in Healthy Subjects
NCT05581992Phase 1Completed
- Sponsor
- Amgen
- Start
- Jan 2020
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of sotorasib in non-small cell lung cancer (NSCLC), sponsored by Amgen. Primary endpoints: Maximum Observed Plasma Concentration at Day 9, Area Under the Plasma Concentration-time Curve from Time Zero to the Last Quantifiable Concentration at Day 9 and 1 more. Started Jan 2020; status: completed.
02
Drugs
sotorasib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT05581992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05581992.